| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at X4 Pharmaceuticals, Inc. (XFOR) have been net sellers, shedding 79,179 shares worth roughly $342K on balance. In the past 30 days, 1 insider bought and 1 sold.
Craig Adam R (Executive Chairman) stands out among recent buyers, now holding an estimated $861K in XFOR.
Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), XFOR's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 333.3K | $860.9K | +4.6K | |
| Pres | 265.3K | $1.18M | - | |
| CFO | 156.0K | $446.2K | -11,767 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 24, 2025 | Baldry Mark58 | Chief Commercial Officer | Sell | 29,159 | $0.45 | $13,241.10 | -23.7% | -60.8% | -74.2% | |
| Jan 24, 2025 | Dibiase Mary71 | Chief Operating Officer | Sell | 22,258 | $0.45 | $10,094.00 | -4.3% | -60.8% | -74.2% | |
| Jan 24, 2025 | Arbet-Engels Christophe | Chief Medical Officer | Sell | 11,624 | $0.45 | $5,284.27 | -45.0% | -60.8% | -74.2% | |
| Nov 15, 2024 | Ragan Paula77 | President and CEO | Sell | 31,897 | $0.39 | $12,583.37 | -3.1% | +24.6% | -69.8% | |
| Nov 15, 2024 | Baldry Mark58 | Chief Commercial Officer | Buy | 35,050 | $0.55 | $19,251.91 | +37.2% | +24.6% | -69.8% | |
| Oct 15, 2024 | Ragan Paula77 | President and CEO | Sell | 31,897 | $0.56 | $17,926.11 | -3.0% | +1.5% | -82.9% | |
| Oct 7, 2024 | Dibiase Mary71 | Chief Operating Officer | Sell | 67,695 | $0.57 | $38,328.91 | -13.0% | +40.0% | -78.3% | |
| Oct 7, 2024 | Taveras Arthur63 | Chief Scientific Officer | Sell | 76,920 | $0.56 | $43,305.96 | -16.5% | +40.0% | -78.3% | |
| Oct 7, 2024 | Mostafa Adam S.75 | Chief Financial Officer | Sell | 230,645 | $0.55 | $126,900.88 | -100% | +40.0% | -78.3% | |
| Oct 7, 2024 | Baldry Mark58 | Chief Commercial Officer | Sell | 11,127 | $0.58 | $6,505.96 | -18.7% | +40.0% | -78.3% |